Texas State University Acquires Rigaku SCXmini Chemical Crystallography Instrument
News Jan 08, 2009
Rigaku Americas Corporation has announced that the Department of Chemistry and Biochemistry at the Texas State University has purchased a Rigaku SCXmini™ benchtop small molecule X-ray diffraction (XRD) crystallography instrument for Cyber-enabled Small Molecule Structure Analysis for Research and Educational Purposes as funded by a Major Research Instrumentation program (MRI) grant from the National Science Foundation (NSF).
A Rigaku SCXmini™ X-ray crystallography system was chosen by Prof. Benjamin Martin (Principal Investigator), Prof. Gary Beall (co-PI), Prof. Michael Blanda (Co-PI), and Prof. Debra Feakes (Co-PI) to enhance the X-ray facilities of the Department of Chemistry and Biochemistry in support of education and research at Texas State and a consortium of "cyber-enabled" collaborators from Lamar University, San Antonio College, Texas Lutheran University and Sam Houston State University.
The SCXmini™ X-ray diffractometer will be employed to strengthen research endeavors and spark new explorations in areas involving: sulfide and selenide materials, solid state linkage isomerism and ligand substitution in transition metal cyanide complexes, conformational isomers of immobilized calixarenes, polyhedral borane anions, sulfido-bridged iron compounds and magnetostructural studies of Ni(II) dimers, and the preparation of titanium complexes as well as a variety of other research topics.
New Chemical Synthesis Process: Synergy of Two Catalysts in One FlaskNews
Researchers report the one-step synthesis of a ketone from an aldehyde by the combination of thiazolium N-heterocyclic carbene and palladium/bisphosphine catalysts in one flask. The two catalysts function in a synergistic manner. This study is expected to lead to new synthesis processes of precursor compounds for medications.READ MORE
Synthesis of Drug-Like Molecules Simplified Using New Cross-Coupling MethodNews
Researchers have designed a new molecule-building method. The technique, described recently in the journal Science, paves the way toward other new chemical reactions and facilitates the synthesis of pharmaceutically-relevant molecules.READ MORE
Domainex Appoints Dr Bodo Spori as Head of Business Development for EuropeNews
Domainex Ltd, a privately-owned drug discovery services company, is pleased to announce the appointment of Dr Bodo Spori as Head of Business Development for Europe.READ MORE
Comments | 0 ADD COMMENT
10th International Conference on Mass Spectrometry and Chromatography
Oct 08 - Oct 09, 2018